Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient

Genes to Cells

Volumn 18, Issue 12, 2013, Pages 1053-1069

  Satoh, Daisuke ^a   Maeda, Tohru ^a,b   Ito, Tetsuya ^c   Nakajima, Yoko ^c   Ohte, Mariko ^a   Ukai, Akane ^a   Nakamura, Katsunori ^a   Enosawa, Shin ^d   Toyota, Masashi ^e   Miyagawa, Yoshitaka ^e   Okita, Hajime ^e   Kiyokawa, Nobutaka ^e   Akutsu, Hidenori ^e   Umezawa, Akihiro ^e   Matsunaga, Tamihide ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b KINJO GAKUIN UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CASPASE 3; CASPASE 9; GLYCOGEN; INDOCYANINE GREEN; LACTIC ACID; LIPOCORTIN 5; PYRUVIC ACID; SUPEROXIDE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC SCREENING; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; HUMAN CELL; LIPID STORAGE; LIVER CELL; NEUTROPHIL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN BINDING;

CELL DIFFERENTIATION; CELLS, CULTURED; CHILD, PRESCHOOL; GLYCOGEN STORAGE DISEASE TYPE I; HEPATOCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEUTROPHILS; OXIDATIVE STRESS;

EID: 84888329754     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12101     Document Type: Article

References (47)

1. Asahina, K., Fujimori, H., Shimizu-Saito, K., Kumashiro, Y., Okamura, K., Tanaka, Y., Teramoto, K., Arii, S. & Teraoka, H. (2004) Expression of the liver-specific gene Cyp7a1 reveals hepatic differentiation in embryoid bodies derived from mouse embryonic stem cells. Genes Cells 9, 1297-1308.
2. Berk, P.D. & Stremmel, W. (1986) Hepatocellular uptake of organic anions. Prog. Liver Dis. 8, 125-144.
3. Borregaard, N., Theilgaard-Mönch, K., Sørensen, O.E. & Cowland, J.B. (2001) Regulation of human neutrophil granule protein expression. Curr. Opin. Hematol. 8, 23-27.
4. Carvajal-Vergara, X., Sevilla, A., D'Souza, S.L., et al. (2010) Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808-812.
5. Cheung, Y.Y., Kim, S.Y., Yiu, W.H., Pan, C.J., Jun, H.S., Ruef, R.A., Lee, E.J., Westphal, H., Mansfield, B.C. & Chou, J.Y. (2007) Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-β. J. Clin. Invest. 117, 784-793.
6. Chou, J.Y. (1988) Regulators of fetal liver differentiation in vitro. Arch. Biochem. Biophys. 263, 378-386.
7. Chou, J.Y., Jun, H.S. & Mansfield, B.C. (2010) Neutropenia in type Ib glycogen storage disease. Curr. Opin. Hematol. 17, 36-42.
8. Chou, J.Y. & Mansfield, B.C. (2011) Recombinant AAV-directed gene therapy for type I glycogen storage diseases. Expert Opin. Biol. Ther. 11, 1011-1024.
9. Correia, C.E., Bhattacharya, K., Lee, P.J., Shuster, J.J., Theriaque, D.W., Shankar, M.N., Smit, G.P. & Weinstein, D.A. (2008) Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am. J. Clin. Nutr. 88, 1272-1276.
10. Cowland, J.B. & Borregaard, N. (1999) The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J. Leukoc. Biol. 66, 989-995.
11. Czop, J.K. (1986) The role of beta-glucan receptors on blood and tissue leukocytes in phagocytosis and metabolic activation. Pathol. Immunopathol. Res. 5, 286-296.
12. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R., Wichterle, H., Henderson, C.E. & Eggan, K. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221.
13. Dissanayake, V.H., Jayasinghe, J.D., Thilakaratne, V. & Jayasekara, R.W. (2010) Novel mutation in SLC37A4 gene in a Sri Lankan boy with glycogen storage disease type Ib associated with very early onset neutropenia. J. Mol. Genet. Med. 5, 262-263.
14. Donadieu, J., Fenneteau, O., Beaupain, B., Mahlaoui, N. & Chantelot, C.B. (2011) Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J. Rare Dis. 6, 26.
15. Fasske, E. & Morgenroth, K. (1985) Functional morphology of phagocytosing alveolar macrophages. Long-term electron microscopic and X-ray microanalytical investigations on the rat model. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 49, 195-208.
16. Fernandes, J., Koster, J.F., Grose, W.F. & Sorgedrager, N. (1974) Hepatic phosphorylase deficiency. Its differentiation from other hepatic glycogenoses. Arch. Dis. Child. 49, 186-191.
17. Friedman, A.D. (2007) Transcriptional control of granulocyte and monocyte development. Oncogene 26, 6816-6828.
18. Guionie, O., Clottes, E., Stafford, K. & Burchell, A. (2003) Identification and characterization of a new human glucose-6-phosphatase isoform. FEBS Lett. 551, 159-164.
19. Kasahara, M., Horikawa, R., Sakamoto, S., Shigeta, T., Tanaka, H., Fukuda, A., Abe, K., Yoshii, K., Naiki, Y., Kosaki, R. & Nakagawa, A. (2009) Living donor liver transplantation for glycogen storage disease type Ib. Liver Transpl. 15, 1867-1871.
20. Kim, S.Y., Jun, H.S., Mead, P.A., Mansfield, B.C. & Chou, J.Y. (2008) Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood 111, 5704-5711.
21. Kuijpers, T.W., Maianski, N.A., Tool, A.T., Smit, G.P., Rake, J.P., Roos, D. & Visser, G. (2003) Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood 101, 5021-5024.
22. Lanier, L.L., Phillips, J.H., Testi, R. (1989) Membrane anchoring and spontaneous release of CD16 (FcR III) by natural killer cells and granulocytes. Eur. J. Immunol. 19, 775-778.
23. Lee, G., Papapetrou, E.P., Kim, H., Chambers, S.M., Tomishima, M.J., Fasano, C.A., Ganat, Y.M., Menon, J., Shimizu, F., Viale, A., Tabar, V., Sadelain, M. & Studer, L. (2009) Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406.
24. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S. & Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
25. Maehr, R., Chen, S., Snitow, M., Ludwig, T., Yagasaki, L., Goland, R., Leibel, R.L. & Melton, D.A. (2009) Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl Acad. Sci. USA 106, 15768-15773.
26. Melis, D., Della-Casa, R., Parini, R., Rigoldi, M., Cacciapuoti, C., Marcolongo, P., Benedetti, A., Gaudieri, V., Andria, G. & Parenti, G. (2008) Vitamin E supplementation improves neutropenia and reduces the frequency of infections in patients with glycogen storage disease type 1b. Eur. J. Pediatr. 168, 1069-1074.
27. Melis, D., Parenti, G., Della-Casa, R., Sibilio, M., Berni-Canani, R., Terrin, G., Cucchiara, S. & Andria, G. (2003) Crohn's like ileo-colitis in patients affected by glycogen storage disease Ib: two years' follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatr. 92, 1415-1421.
28. Melis, D., Pivonello, R., Parenti, G., Della-Casa, R., Salerno, M., Lombardi, G., Sebastio, G., Colao, A. & Andria, G. (2007) Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. J. Pediatr. 150, 300-305.
29. Morishima, T., Watanabe, K., Niwa, A., Fujino, H., Matsubara, H., Adachi, S., Suemori, H., Nakahata, T. & Heike, T. (2011) Neutrophil differentiation from human-induced pluripotent stem cells. J. Cell. Physiol. 226, 1283-1291.
30. Muller, M. & Jansen, P.L. (1998) The secretory function of the liver: New aspects of hepatobiliary transport. J. Hepatol. 28, 344-354.
31. Narisawa, K., Igarashi, Y., Otomo, H. & Tada, K. (1978) A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system. Biochem. Biophys. Res. Commun. 83, 1360-1364.
32. Okabayashi, K. & Asashima, M. (2003) Tissue generation from amphibian animal caps. Curr. Opin. Genet. Dev. 13, 502-507.
33. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K. & Daley, G.Q. (2008) Disease-specific induced pluripotent stem (iPS) cells. Cell 134, 877-886.
34. Pulido, R., Lacal, P., Mollinedo, F. & Sánchez-Madrid, F. (1989) Biochemical and antigenic characterization of CD45 polypeptides expressed on plasma membrane and internal granules of human neutrophils. FEBS Lett. 249, 337-342.
35. Rashid, S.T., Corbineau, S., Hannan, N., Marciniak, S.J., Miranda, E., Alexander, G., Huang-Doran, I., Griffin, J., Ahrlund-Richter, L., Skepper, J., Semple, R., Weber, A., Lomas, D.A. & Vallier, L. (2010) Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Invest. 120, 3127-3136.
36. Raya, A., Rodríguez-Pizà, I., Guenechea, G., et al. (2009) Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53-59.
37. Sakai, K., Hattori, T., Sagawa, K., Yokoyama, M. & Takatsuki, K. (1987) Biochemical and functional characterization of MCS-2 antigen (CD13) on myeloid leukemic cells and polymorphonuclear leukocytes. Cancer Res. 47, 5572-5576.
38. Scott, F.L., Denault, J.B., Riedl, S.J., Shin, H., Renatus, M. & Salvesen, G.S. (2005) XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J. 24, 645-655.
39. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G.W., Cook, E.G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., Isacson, O. & Jaenisch, R. (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977.
40. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. & Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 13, 861-872.
41. Tsuchiya, H., Matsunaga, T., Aikawa, K., Kamada, N., Nakamura, K., Ichikawa, H., Sasaki, K. & Ohmori, S. (2012) Evaluation of human embryonic stem cell-derived hepatocyte-like cells for detection of CYP1A inducers. Drug Metab. Pharmacokinet. 27, 598-604.
42. Visser, G., de Jager, W., Verhagen, L.P., Smit, G.P., Wijburg, F.A., Prakken, B.J., Coffer, P.J. & Buitenhuis, M. (2012) Survival, but not maturation, is affected in neutrophil progenitors from GSD-1b patients. J. Inherit. Metab. Dis. 35, 287-300.
43. Yamada, T., Yoshikawa, M., Kanda, S., Kato, Y., Nakajima, Y., Ishizaka, S. & Tsunoda, Y. (2002) In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 20, 146-154.
44. Ye, L., Chang, J.C., Lin, C., Sun, X., Yu, J. & Kan, Y.W. (2009) Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl. Acad. Sci. USA 106, 9826-9830.
45. Yiu, W.H., Pan, C.J., Allamarvdasht, M., Kim, S.Y. & Chou, J.Y. (2007) Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice. Gene Ther. 14, 219-226.
46. Yiu, W.H., Pan, C.J., Mead, P.A., Starost, M.F., Mansfield, B.C. & Chou, J.Y. (2009) Normoglycemia alone is insufficient to prevent long term complications of hepatocellular adenoma in glycogen storage disease type Ib mice. J. Hepatol. 51, 909-917.
47. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I. & Thomson, J.A. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.